Crossmark

A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience

Crossref DOI link: https://doi.org/10.1007/s13760-018-0978-9

Published Online: 2018-07-10

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yalinay Dikmen, Pınar https://orcid.org/0000-0001-7112-2142
Kosak, Seda

Ilgaz Aydinlar, Elif

Sagduyu Kocaman, Ayse
License Information

Text and Data Mining valid from 2018-07-10
More Information

Article History

Received: 19 February 2018

Accepted: 5 July 2018

First Online: 10 July 2018

Compliance with ethical standards

:

: The authors declare that they have no competing of interests.

: The study protocol was conducted in accordance to the ethical principles stated in the “Helsinki Declaration” and approved by the Ethical Committee of Acıbadem University.

: Verbal informed constent was obtained from all the participants during the phone interviews before they enrolled on the study.